Uncategorized
Featured Stories
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
DaVita Inc. 1st Quarter 2026 Results
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita HealthCare Partners Inc. Announces Results as of Consent Payment Deadline and Execution of Supplemental Indenture related to its 6 3/8% Senior Notes due 2018
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced the execution of the supplemental indenture related to its previously announced consent solicitation (the “Consent…
-
DaVita HealthCare Partners Inc. Announces Pricing of $1.75 Billion Senior Notes
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced the pricing of $1.75 billion principal amount of 5.125% Senior Notes due 2024 (the “Senior Notes”). The offering is…
-
DaVita HealthCare Partners Inc. Announces Offering of $1.75 Billion Senior Notes
DaVita HealthCare Partners Inc. (NYSE: DVA) (the “Company”) today announced that it intends to offer, subject to market and other conditions, $1.75 billion principal amount of senior notes due…
-
DaVita Rx Delivers 15 Millionth Prescription
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today that it has filled its 15 millionth prescription since…
-
DaVita Reports on 2013 Corporate Social Responsibility Progress
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the release of its 2013 Community Care report, which…